1. DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1

   • Alina Rosinha
   • Joana Assis
   • Rui Medeiros

   Original Paper 22 October 2015 Article: 255

   

2. The human chemokine receptor CCRL2 suppresses chemotaxis and invasion by blocking CCL2-induced phosphorylation of p38 MAPK in human breast cancer cells

   • Lei-Ping Wang
   • Jun Cao
   • Zhou-Luo Ou

   Original Paper 20 October 2015 Article: 254

   

3. Evaluation of immune responses of gastric cancer patients treated by laparoscopic and open gastrectomy

   • Ming Cui
   • Chaofan Gong
   • Xiangqian Su

   Original Paper 15 October 2015 Article: 253

   

4. Radiotherapy combined docetaxel and oxaliplatin chemotherapy is effective in patients with locally advanced nasopharyngeal carcinoma

   • Feng Pan
   • Zhihua Ruan
   • Houjie Liang

   Original Paper 15 October 2015 Article: 252

   

5. The effect of superoxide anion and hydrogen peroxide imbalance on prostate cancer: an integrative in vivo and in vitro analysis

   • Maiquidieli Dal Berto
   • Claudia Giuliano Bica
   • Ivana Beatrice Mânica da Cruz

   Original Paper 14 October 2015 Article: 251

   

6. IL-37 mediates the antitumor activity in renal cell carcinoma

   • Yazhuo Jiang
   • Yili Wang
   • Yonggang Xu

   Original Paper 13 October 2015 Article: 250

   

7. Clinicopathologic characteristics of anterior prostate cancer (APC), including correlation with previous biopsy pathology

   • Martin J. Magers
   • Tianyu Zhan
   • Rohit Mehra

   Original Paper 06 October 2015 Article: 249

   

8. Effect of the association of 1-methyl-DL-tryptophan with paclitaxel on the expression of indoleamine 2,3-dioxygenase in cultured cancer cells from patients with breast cancer

   • Maria Letícia Baptista Salvadori
   • Pedro Kastein Faria da Cunha Bianchi
   • José Roberto Kfoury Jr

   Short Communication 06 October 2015 Article: 248

9. A phase I study of adjuvant intensity-modulated radiotherapy with concurrent paclitaxel and cisplatin for cervical cancer patients with high risk factors

   • Pei Shu
   • Yali Shen
   • Zhiping Li

   Original Paper 03 October 2015 Article: 247

10. Loss of heterozygosity for chromosomal regions 15q14-21.1, 17q21.31, and 13q12.3-13.1 and its relevance for prostate cancer

    • Maria Nowacka-Zawisza
    • Ewa Forma
    • Wanda M. Krajewska

    Original Paper Open access 03 October 2015 Article: 246

    

11. Cholangiocarcinoma: from molecular biology to treatment

    • Ana F. Brito
    • Ana M. Abrantes
    • Maria F. Botelho

    Review Paper 01 October 2015 Article: 245

    

12. Erratum to: Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma

    • Omar Abdel-Rahman
    • Manal Abdel-Wahab
    • Mahmoud Ellithy

    Erratum 26 September 2015 Article: 244